March 15, 2022

National Quality Initiatives Amplify Health Systems’ Focus on Effective Glycemic Management as Glytec Fortifies Industry Leadership Position

National Quality Initiatives Amplify Health Systems’ Focus on Effective Glycemic Management as Glytec Fortifies Industry Leadership Position Strategic Partnerships, Product Innovation and Customer Expansion Underpin Insulin Dosing Technology Company’s Sustained Growth WALTHAM, Mass. (March 15, 2022) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced that it has significantly expanded the deployment of …

February 10, 2022

Glytec and Roche strike partnership on insulin management

JANUARY 12, 2022 Glytec and Roche strike partnership on insulin management This digital health collaboration combines Roche’s expertise in medical devices and IT solutions with Glytec’s FDA-cleared insulin dosing decision support software, Glucommander, to address the challenges with inpatient blood sugar management at the hospital bedside. Glucommander will be the first software application available to run on Roche’s smart-device next-generation hospital blood …

Glytec partners with Roche to enhance insulin dosing decision support software

JANUARY 12, 2022 by SEAN WHOOLEY Glytec partners with Roche to enhance insulin dosing decision support software Glytec announced today that it entered into a strategic partnership with Roche Diagnostics USA for a digital health collaboration. Waltham, Massachusetts-based Glytec’s partnership combines its FDA-cleared Glucommander insulin dosing decision support software with Roche’s expertise in medical devices and IT solutions in an effort to address …

JPM 2022: Roche launches smart, hand-held glucose meter for the hospital bedside

JANUARY 12, 2022 by Conor Hale JPM 2022: Roche launches smart, hand-held glucose meter for the hospital bedside Roche has launched its new point-of-care blood glucose monitor designed for hospital professionals, with a companion device shaped like a touchscreen smartphone that will run its own apps. The cobas pulse will start shipping to select countries in Europe, carrying a CE …

Roche Taps Glytec for Digital Health Partnership

JANUARY 12, 2022 Amanda Petersen Roche Taps Glytec for Digital Health Partnership The partnership will leverage Glytec’s insulin dosing support software to address challenges with hospital inpatient blood sugar management. Glytec, a Gold winner in the 2021 Medical Design Excellence Awards competition, has nabbed a rather big partnership with Roche that will ultimately benefit countless hospital patients and their clinicians. Through a digital …

January 25, 2022

Glytec And Nebraska Medicine Establish Strategic Partnership to Advance Patient Safety and Innovation Around Insulin Management

Glytec And Nebraska Medicine Establish Strategic Partnership to Advance Patient Safety and Innovation Around Insulin Management Leader in Endocrinology Research Implements eGlycemic Management System Across Hospitals, Dedicates Resources Towards Research and Development WALTHAM, Mass. (January 25, 2022) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced a new strategic partnership with Nebraska …

January 14, 2022

Glytec garners cybersecurity certification for insulin management system

JANUARY 4, 2021 By: Sean Whooley Glytec garners cybersecurity certification for insulin management system Glytec announced today that its eGlycemic Management System received certified status for information security from HITRUST. Waltham, Massachusetts-based Glytec’s certification validates its platform’s ability to meet the highest standards for protecting sensitive data and information when working with its health system customers. According to a news release, …

January 12, 2022

Glytec and Roche Announce Strategic Partnership to Bring Digital Health Innovation in Glycemic Decision Support to the Hospital Bedside

Glytec and Roche Announce Strategic Partnership to Bring Digital Health Innovation in Glycemic Decision Support to the Hospital Bedside As CMS Creates an Emphasis on Hyperglycemia and Hypoglycemia Rates in the Hospital, Partnership Aims to Transform the Standard of Care WALTHAM, MASS. (January 12, 2022) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today …

January 4, 2022

Glytec Achieves HITRUST CSF® Certification to Manage Risk, Improve Security Posture and Meet Compliance Requirements

Glytec Achieves HITRUST CSF® Certification to Manage Risk, Improve Security Posture and Meet Compliance Requirements HITRUST CSF Certification validates Glytec is committed to meeting key regulations and protecting sensitive information. WALTHAM, MASS. (January 4, 2022) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced that Glytec’s eGlycemic Management System®, including Glucommander™, has …

September 24, 2021

Why the Next Wave of Insulin Innovation Needs to Focus on Inpatient Management

AUGUST 22 2021 By Dr. Jordan Messler Why the Next Wave of Insulin Innovation Needs to Focus on Inpatient Management In 1921, Sir Frederick G. Banting, Charles H. Best and JJR Macleod discovered insulin at the University of Toronto. This innovation changed the course of history for individuals with type 1 diabetes, caregivers and others who require insulin. The 100 …

July 16, 2021

John Downey, Chief Commercial Officer at Glytec, on VatorNews podcast

JULY 14 2021 Steven Loeb John Downey, Chief Commercial Officer at Glytec, on VatorNews podcast Glytec’s electronic glycemic management system uses data to determine patient insulin levels Steven Loeb and Bambi Francisco interview John Downey, Chief Commercial Officer at Glytec, a provider of electronic glycemic management systems (eGMS), using real-time data to ensure that hospitals give patients the right level of insulin. …

July 15, 2021

Glytec appoints chief medical officer

JULY 13 2021 Sean Whooley Glytec appoints chief medical officer Cloud-based insulin management software developer Glytec announced today that it appointed Dr. Jordan Messler as chief medical officer. Messler’s responsibilities as the company’s CMO include spearheading continuous improvement initiatives for Glytec’s clinical strategy and product development. Additionally, Messler will be supporting the delivery, customer, quality and regulatory teams to ensure ethical …

June 22, 2021

Glytec Appoints Nausheen Moulana as Chief Technology Officer

Glytec Appoints Nausheen Moulana as Chief Technology Officer Engineering and Technology Veteran to Lead Company’s Product Vision and Support Growing Demand for Insulin Dosing Software and Inpatient Glycemic Management WALTHAM, MASS. (June 22, 2021) –  Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced the appointment of Nausheen Moulana as Chief Technology Officer. …

May 17, 2021

Glytec Raises $21 Million

APRIL 26 2021 Glytec Raises $21 Million Glytec, the only provider of insulin management software across the continuum of care, today announced $21 million in financing from Silicon Valley Bank (SVB), Savitr Capital and other private investors. The funding will fuel Glytec’s mission of revolutionizing the role glycemic management plays in the hospital across every department. The combined $9 million …

Glytec Lands $21M Venture & Debt Funding

APRIL 26 2021 Glytec Lands $21M Venture & Debt Funding WALTHAM, MA, Glytec, a provider of insulin management software, announced $21 million in financing. >> Click here for more funding data on Glytec >> To export Glytec funding data to PDF and Excel, click here Glytec, a provider of insulin management software, announced $21 million in financing from Silicon Valley …

May 15, 2021

Most Riveting Takeaways from the Medtech Design Summit 2021

MAY 13 2021 Amanda Pedersen Most Riveting Takeaways from the Medtech Design Summit 2021 Finalists in the 2021 Medical Design Excellence Awards program shared best practices and lessons learned from the design process. These were among the most compelling takeaways from the discussions. The Medtech Design Summit is available to watch on demand here. View slideshow: https://www.mddionline.com/design-engineering/most-riveting-takeaways-medtech-design-summit-2021/gallery?slide=1 – This article originally …

May 14, 2021

Medical Design Excellence Awards (MDEA) Unveils 2021 Winners

MAY 13 2021 Medical Design Excellence Awards (MDEA) Unveils 2021 Winners SANTA MONICA, Calif.–(BUSINESS WIRE)–Medical Design Excellence Awards (MDEA), a prestigious award program recognizing cutting-edge achievements in medical product design, today announced the 2021 winners during the all-new Medtech Design Summit, during which Novo; Protolabs; HS Design, a SteriPack company; and Trelleborg sponsored sessions and Bressler Group, Inertia Engineering, and …

May 10, 2021

Glytec Raises $21M to Fix Hospital Insulin Management

APRIL 26 2021 Fred Pennic Glytec Raises $21M to Fix Hospital Insulin Management What You Should Know: – Glytec announced $21M in funding today from Silicon Valley Bank, Savitr Capital and others to help address the challenge that 90% of hospitals in the U.S. face with insulin management. – Glytec’s insulin management solution, eGMS helps providers track blood glucose data, detect and alert patients in glycemic disarray, provide personalized insulin dosing regimens, and …

Glytec Raises $21 Million To Set the Standard for Hospital Insulin Dosing and Glycemic Management

APRIL 26 2021 Glytec Raises $21 Million To Set the Standard for Hospital Insulin Dosing and Glycemic Management WALTHAM, MASS. (April 26, 2021) – Glytec, the only provider of insulin management software across the continuum of care, today announced $21 million in financing from Silicon Valley Bank (SVB), Savitr Capital and other private investors. Editor’s Note: This article originally posted …

Insulin management company Glytec scores $21M to fuel growth

APRIL 27 2021 Mallory Hackett Insulin management company Glytec scores $21M to fuel growth The company collected $9 million in debt financing from SVB and $12 million in equity investments led by Savitr positions, according to its announcement. Glytec, an insulin management software company, has received $21 million in funding from Silicon Valley Bank, Savitr Capital and other private investors. …